TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Adherence to Physician Recommended CAM Therapies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IVF pregnancy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative pregnancy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-intranasal steroid concomitant medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Uricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUClast of plasma levoketoconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of plasma levoketoconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of plasma levoketoconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Confidence in Survivorship Information instrument score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acoustic Sensitivity of Implanted Carina Microphone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of Response of Carina Microphone : Accelerometer for Acoustic Stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carina Maximum Stable Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Short Form (SF-36) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: New Bone Formation at Extraction/Xenograft Site (Histological Evaluation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New Bone Formation at Extraction/Xenograft Site (Clinical Evaluation with Dental Probe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMT of neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of vaccine associated serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: GMT of hemagglutination inhibition assay (HAI) antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incremental area under the curve (iAUC) for total plasma GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: time to reach the minimum muscular oxygenation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of muscular oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve Over One Dosing Interval (AUC [0 to Tau])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refractory period of the Right Ventricle (RV) and Right Atrium (RA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of atrial and ventricular extrasystoles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacokinetics (PK) of conivaptan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein binding of conivaptan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of successful opioid rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC Pain Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI Pain Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of pidilizumab combined with lenalidomide
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Overall response rate in responding patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Achieved Sitting Alone for at Least 10 Seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of discharge diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Improvement of signs and symptoms of vulvovaginal atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verification of Axillary Node Metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Biochemical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical symptoms assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity (HI antibody titer) - first vaccine
Endpoint domain: Physiological/clinical
Primary endpoint: Immunogenicity (HI antibody titer) - second vaccine
Endpoint domain: Physiological/clinical
Primary endpoint: Improvement of IBS-SSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of stable isotope labeled 25(OH)D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change From Baseline in Average Lissamine Green Staining in the Study Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Social functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Percentage of coated platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: fMRI brain activation (BOLD) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success of NIV withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Go/No-Go Task Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of traditional hemodynamic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes of volume management parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Body temperature from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal length of the muscles treated by Botulinum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Dialysis dose (spKt/V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient reported back pain levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Delimitation of the wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Detection of mandibular bone invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time for recovered menstrual cycle after discontinuation of oral contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian reserve parameters before and after discontinuation of combined oral contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percent correct consonants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of in vivo validation with in vitro caries detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in level of approach on the Behavioural Approach Test (BAT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: acid bases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longest Duration of Achieved Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage Samples Submitted Negative for Crack Cocaine Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Completing 4, 8 and 12 Weeks of Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of successful application of the NP-PWD device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Self-report measures of alcohol-related problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IUD expulsion risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI BOLD Signal Changes in Left Amygdala
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI Functional Connectivity Changes in VPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: STI diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Subjective effect during 24 hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Patients With Clinical Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Type 2 Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adhesion reformation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cormack and Lehane laryngoscopy grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of CDK-002
Endpoint domain: Adverse events/effects
Primary endpoint: CDSS (Calgary Depression Scale for Schizophrenia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAF (Global Assessment of Functioning)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QLS (Quality of Life Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change (%) in the sum of diameters of target lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Common Toxicity Criteria (CTC) score
Endpoint domain: Adverse events/effects
Primary endpoint: Sum CTC score
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Annualized Bleed Rate (ABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreases fentanyl consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety (incidence of complications)
Endpoint domain: Adverse events/effects
Primary endpoint: HINT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Carotid-femoral Pulse Wave Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in UPDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assay of mtDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood Disorder Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Median Dyspareunia Pain Scores After 4 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Median Pain Scores for Intercourse After 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle microRNAs and myokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole body energy metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: motoric function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Immunogenicity of MMR vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of MMR vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Consistency of production of MMR vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second eye mean absolute error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comorbid conditions of Depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comorbid conditions of alcohol dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant or ≥ Grade 3 changes in safety laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of AMG 337
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Total Nasal Signs and Symptoms Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Emergent Adverse Events of NCI CTCAE ≥Grade 3
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Emergent Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Decreased Maternal Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decreased Domestic Violence
Endpoint domain: Adverse events/effects
Primary endpoint: Improved General Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma Ellagic Acid Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of GLPG0974
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GR-GRE Binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Radiation Dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Radiation Dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of Human DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of HPV DNA (primarily HPV16)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RLUs or ct values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC) of ROC curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in days of illicit heroin use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Fugl-Meyer Assessment (UE portion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Box & Block Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of S95005
Endpoint domain: Adverse events/effects
Primary endpoint: Dose Limiting Toxicity (DLT) of S95005
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of change for Triglyceride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tampa Kinesiophobia Scale (TSK)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: International Physical Activity Questionnaire Short Form (IPAQ-SF)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fall Efficacy Scale (FES)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of patients achieving fracture union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional acceptability of the semen collection device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time course of pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Noradrenalin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Behavioral Ratings of Executive Functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroke and systemic embolization
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of intrauterine scar area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of intrauterine adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of specific copy number variants (CNVs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in relaxation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and Tolerability Based on the Safety Variables
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC(0-24 Hours))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Nausea and Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Activity in diverse cortical regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Parallel behavioral performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-Reported Pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed Pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response Rate
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to receipt of ASD services/recommended services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Normalization of urine culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain due to Dentin Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in arsenical melanosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cardiac MRI infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain PDE10 occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain PDE10 inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Sleep duration by sleep diary
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change of Sleep duration by actigraphy
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: cytopenic abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bath Ankylosing Spondylitis Metrology Index (BASMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in reported pain intensity score (PROMIS Pain Intensity 1A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of Treatment Failure at 6mo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Psychological impact assessed by PSS10 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological impact assessed by HADS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number and severity of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: metabolic phenotype of colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient Experience of Medication Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Shared Decision Making Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Maximum tolerated dose (MTD) determined by incidence of dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 6 Minute walk distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Intensity Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful introduction of cholangiography catheter into cystic duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum total testosterone average concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of ENL recurrence episodes per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in low density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes